293 related articles for article (PubMed ID: 16856906)
1. Late non-relapse mortality among adult autologous stem cell transplant recipients: a nation-wide analysis of 1,482 patients transplanted in 1990-2003.
Jantunen E; Itälä M; Siitonen T; Koivunen E; Leppä S; Juvonen E; Kuittinen O; Lehtinen T; Koistinen P; Nyman H; Nousiainen T; Volin L; Remes K
Eur J Haematol; 2006 Aug; 77(2):114-9. PubMed ID: 16856906
[TBL] [Abstract][Full Text] [Related]
2. Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients.
Jantunen E; Itälä M; Lehtinen T; Kuittinen O; Koivunen E; Leppä S; Juvonen E; Koistinen P; Wiklund T; Nousiainen T; Remes K; Volin L
Eur J Haematol; 2006 Mar; 76(3):245-50. PubMed ID: 16412136
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
Majhail NS; Weisdorf DJ; Defor TE; Miller JS; McGlave PB; Slungaard A; Arora M; Ramsay NK; Orchard PJ; MacMillan ML; Burns LJ
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1065-72. PubMed ID: 17084370
[TBL] [Abstract][Full Text] [Related]
4. Estimating late adverse events using competing risks after autologous stem-cell transplantation in aggressive non-Hodgkin lymphoma patients.
Ruiz-Soto R; Sergent G; Gisselbrecht C; Larghero J; Ertault M; Hennequin C; Manson J; de Kerviler E; Briere J; Mounier N
Cancer; 2005 Dec; 104(12):2735-42. PubMed ID: 16284986
[TBL] [Abstract][Full Text] [Related]
5. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
[TBL] [Abstract][Full Text] [Related]
6. Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience.
Ulrickson M; Aldridge J; Kim HT; Hochberg EP; Hammerman P; Dube C; Attar E; Ballen KK; Dey BR; McAfee SL; Spitzer TR; Chen YB
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1447-54. PubMed ID: 19822305
[TBL] [Abstract][Full Text] [Related]
7. Autologous stem cell transplantation in elderly (>60 years) patients with non-Hodgkin's lymphoma: a nation-wide analysis.
Jantunen E; Itälä M; Juvonen E; Leppä S; Keskinen L; Vasala K; Remes K; Wiklund T; Elonen E; Nousiainen T
Bone Marrow Transplant; 2006 Feb; 37(4):367-72. PubMed ID: 16415893
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: a feasible and effective salvage treatment for lymphoid malignancies.
Clavio M; Garrone A; Pierri I; Michelis GL; Balocco M; Albarello A; Varaldo R; Canepa P; Miglino M; Ballerini F; Canepa L; Gobbi M
Oncol Rep; 2005 Oct; 14(4):933-40. PubMed ID: 16142354
[TBL] [Abstract][Full Text] [Related]
9. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Brown JR; Yeckes H; Friedberg JW; Neuberg D; Kim H; Nadler LM; Freedman AS
J Clin Oncol; 2005 Apr; 23(10):2208-14. PubMed ID: 15753460
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation.
Wadehra N; Farag S; Bolwell B; Elder P; Penza S; Kalaycio M; Avalos B; Pohlman B; Marcucci G; Sobecks R; Lin T; Andrèsen S; Copelan E
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1343-9. PubMed ID: 17162217
[TBL] [Abstract][Full Text] [Related]
11. Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma.
Rodriguez R; Nademanee A; Ruel N; Smith E; Krishnan A; Popplewell L; Zain J; Patane K; Kogut N; Nakamura R; Sarkodee-Adoo C; Forman SJ
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1326-34. PubMed ID: 17162215
[TBL] [Abstract][Full Text] [Related]
12. Autologous stem cell transplantation in patients with chronic lymphocytic leukaemia: the Finnish experience.
Jantunen E; Itälä M; Siitonen T; Juvonen E; Koivunen E; Koistinen P; Volin L; Remes K; Nousiainen T
Bone Marrow Transplant; 2006 Jun; 37(12):1093-8. PubMed ID: 16699533
[TBL] [Abstract][Full Text] [Related]
13. Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients.
Jantunen E; Salonen J; Juvonen E; Koivunen E; Siitonen T; Lehtinen T; Kuittinen O; Leppä S; Anttila VJ; Itälä M; Wiklund T; Remes K; Nousiainen T
Eur J Haematol; 2004 Sep; 73(3):174-8. PubMed ID: 15287914
[TBL] [Abstract][Full Text] [Related]
14. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.
Rodrigues CA; Sanz G; Brunstein CG; Sanz J; Wagner JE; Renaud M; de Lima M; Cairo MS; Fürst S; Rio B; Dalley C; Carreras E; Harousseau JL; Mohty M; Taveira D; Dreger P; Sureda A; Gluckman E; Rocha V
J Clin Oncol; 2009 Jan; 27(2):256-63. PubMed ID: 19064984
[TBL] [Abstract][Full Text] [Related]
15. Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation.
Villela L; Sureda A; Canals C; Sanz MA; Martino R; Valcárcel D; Altés A; Briones J; Gómez M; Brunet S; Sierra J
Haematologica; 2003 Mar; 88(3):300-5. PubMed ID: 12651269
[TBL] [Abstract][Full Text] [Related]
16. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
[TBL] [Abstract][Full Text] [Related]
17. Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma.
Auner HW; Sill H; Mulabecirovic A; Linkesch W; Krause R
Ann Hematol; 2002 Jul; 81(7):374-7. PubMed ID: 12185506
[TBL] [Abstract][Full Text] [Related]
18. Autologous stem cell transplantation in patients with high-risk plasmacytoma.
Jantunen E; Koivunen E; Putkonen M; Siitonen T; Juvonen E; Nousiainen T
Eur J Haematol; 2005 May; 74(5):402-6. PubMed ID: 15813914
[TBL] [Abstract][Full Text] [Related]
19. Autologous stem cell transplantation for chronic lymphocytic leukemia.
Dreger P; Brand R; Michallet M
Semin Hematol; 2007 Oct; 44(4):246-51. PubMed ID: 17961723
[TBL] [Abstract][Full Text] [Related]
20. Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer.
Porrata LF; Ingle JN; Litzow MR; Geyer S; Markovic SN
Bone Marrow Transplant; 2001 Nov; 28(9):865-71. PubMed ID: 11781647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
